TRIB Stock Analysis: Buy, Sell, or Hold?

TRIB - Trinity Biotech plc

In Vitro & In Vivo Diagnostic Substances
$0.78
-0.04 (-4.55%) ▼
5d: -16.63%
30d: +4.76%
90d: -21.83%
WAIT
LOW Confidence
Last Updated: February 3, 2026

Get Alerted When TRIB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: TRIB is down 16.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: TRIB is currently trading at $0.78, which is considered fair relative to its 30-day fair value range of $0.71 to $0.88.

Technical Outlook: Technically, TRIB is in a strong uptrend. Immediate support is located at $0.69, while resistance sits at $0.95. Short-term momentum is weak, with the stock down 4.5% recently.

Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $3.00 (+283.8%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Fair Price Range $0.71 - $0.88
Company Quality Score 49/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 69.5%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (45/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-4.5%)
  • BULLISH: Trading 283.8% below Wall St target ($3.00)
  • WARNING: Recommendation downgraded due to -16.6% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $0.71 - $0.88
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $0.69
Resistance Level $0.95
Current Trend Strong Uptrend

Fundamental Context

Forward P/E (Next Year Est.) -0.72
Wall Street Target $3.00 (+283.8%)
Revenue Growth (YoY) 18.1%
Earnings Growth (YoY) -77.3%
Profit Margin -51.6%
Last updated: February 03, 2026 9:57 PM ET
Data refreshes hourly during market hours. Next update: 10:57 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Medical Devices Stocks

Top-rated stocks in Medical Devices by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
SYK
Stryker Corporation
BUY
32 analysts
$424 67 BUY
DXCM
DexCom Inc
STRONG BUY
26 analysts
$85 57 HOLD
ABT
Abbott Laboratories
BUY
28 analysts
$134 62 BUY
MDT
Medtronic PLC
BUY
32 analysts
$111 65 BUY
EW
Edwards Lifesciences Corp
HOLD
32 analysts
$97 56 HOLD

More Analysis for TRIB

TRIB Technical Chart TRIB Price Prediction TRIB Investment Advisor TRIB Fair Price Analyzer TRIB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals